Influence of Health System Affiliation and Pain Manifestation on Advanced Oral Cavity Squamous Cell Carcinoma Risk: A Retrospective Cohort Study in a Latin American Population
Abstract
:1. Introduction
2. Materials and Methods
2.1. Population and Sample
2.2. Selection Criteria
2.3. Studied Characteristics
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Chamoli, A.; Gosavi, A.S.; Shirwadkar, U.P.; Wangdale, K.V.; Behera, S.K.; Kurrey, N.K.; Kalia, K.; Mandoli, A. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021, 121, 105451. [Google Scholar] [CrossRef] [PubMed]
- Bray, F.; Laversanne, M.; Sung, H.; Ferlay, J.; Siegel, R.L.; Soerjomataram, I.; Jemal, A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2024, 74, 229–263. [Google Scholar] [CrossRef] [PubMed]
- Sarode, G.; Maniyar, N.; Sarode, S.C.; Jafer, M.; Patil, S.; Awan, K.H. Epidemiologic aspects of oral cancer. Dis. Mon. 2020, 66, 100988. [Google Scholar] [CrossRef] [PubMed]
- Lawrence, M.S.; Sougnez, C.; Lichtenstein, L.; Cibulskis, K.; Lander, E.; Gabriel, S.B.; Getz, G.; Ally, A.; Balasundaram, M.; Birol, I.; et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015, 517, 576–582. [Google Scholar]
- Fonseca, A.U.; Felix, J.P.; Pinheiro, H.; Vieira, G.S.; Mourão, C.; Monteiro, J.C.G.; Soares, F. An Intelligent System to Improve Diagnostic Support for Oral Squamous Cell Carcinoma. Healthcare 2023, 11, 2675. [Google Scholar] [CrossRef]
- Valdez, J.A.; Brennan, M.T. Impact of Oral Cancer on Quality of Life. Dent. Clin. N. Am. 2018, 62, 143–154. [Google Scholar] [CrossRef]
- Vilarim, R.D.C.B.; Tavares, M.R.; de Siqueira, S.R.D.T.; Jales, S.M.D.C.P.; Formigoni, G.G.S.; Teixeira, M.J.; de Siqueira, J.T.T. Characteristics and prevalence of orofacial pain as an initial symptom of oral and oropharyngeal cancer and its impact on the patient’s functionality and quality of life. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2022, 134, 457–464. [Google Scholar] [CrossRef]
- Kerdpon, D.; Jantharapattana, K.; Sriplung, H. Factors related to diagnostic delay of oral squamous cell carcinoma in southern Thailand: Revisited. Oral Dis. 2018, 24, 347–354. [Google Scholar] [CrossRef]
- Noonan, B. Understanding the reasons why patients delay seeking treatment for oral cancer symptoms from a primary health care professional: An integrative literature review. Eur. J. Oncol. Nurs. 2014, 18, 118–124. [Google Scholar] [CrossRef]
- Ruan, Y.; Heer, E.; Warkentin, M.T.; Jarada, T.N.; O’sullivan, D.E.; Hao, D.; Ezeife, D.; Cheung, W.; Brenner, D.R. The association between neighborhood-level income and cancer stage at diagnosis and survival in Alberta. Cancer 2024, 130, 563–575. [Google Scholar] [CrossRef]
- McMaughan, D.J.; Oloruntoba, O.; Smith, M.L. Socioeconomic status and access to healthcare: Interrelated drivers for healthy aging. Front. Public Health 2020, 8, 231. [Google Scholar] [CrossRef] [PubMed]
- Lueckmann, S.L.; Hoebel, J.; Roick, J.; Markert, J.; Spallek, J.; Knesebeck, O.v.D.; Richter, M. Socioeconomic inequalities in primary-care and specialist physician visits: A systematic review. Int. J. Equity Health 2021, 20, 58. [Google Scholar] [CrossRef] [PubMed]
- Lago, S.; Cantarero, D.; Rivera, B.; Pascual, M.; Blázquez-Fernández, C.; Casal, B.; Reyes, F. Socioeconomic status, health inequalities and non-communicable diseases: A systematic review. J. Public Health 2018, 26, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Costa, E.M.; Rodrigues, E.S.M.; de Sousa, F.S.; Pimentel, F.B.; Lopes, M.B.S.; Vissoci, J.R.N.; Thomaz, E.B.A.F. The Brazilian National Oral Health Policy and oral cancer mortality trends: An autoregressive integrated moving average (ARIMA) model. PLoS ONE 2023, 18, e0291609. [Google Scholar] [CrossRef] [PubMed]
- Vázquez, M.L.; Vargas, I.; Rubio-Valera, M.; Aznar-Lou, I.; Eguiguren, P.; Mogollón-Pérez, A.S.; Torres, A.L.; Peralta, A.; Dias, S.; Jervelund, S.S.; et al. Improving equity in access to early diagnosis of cancer in different healthcare systems of Latin America: Protocol for the EquityCancer-LA implementation-effectiveness hybrid study. BMJ Open 2022, 12, e067439. [Google Scholar] [CrossRef]
- Pinto, J.A.; Pinillos, L.; Villarreal-Garza, C.; Morante, Z.; Villarán, M.V.; Mejía, G.; Caglevic, C.; Aguilar, A.; Fajardo, W.; Usuga, F.; et al. Barriers in Latin America for the management of locally advanced breast cancer. Ecancermedicalscience 2019, 13, 897. [Google Scholar] [CrossRef]
- Piñeros, M.; Sánchez, R.; Perry, F.; García, O.A.; Ocampo, R.; Cendales, R. Delay for diagnosis and treatment of breast cancer in Bogotá, Colombia. Salud Publica Mex. 2011, 53, 478–485. [Google Scholar]
- Brand, N.R.; Qu, L.G.; Chao, A.; Ilbawi, A.M. Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review. Oncologist 2019, 24, e1371–e1380. [Google Scholar] [CrossRef]
- Unger-Saldaña, K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J. Clin. Oncol. 2014, 5, 465–477. [Google Scholar] [CrossRef]
- Vaccarella, S.; Lortet-Tieulent, J.; Saracci, R.; Conway, D.I.; Straif, K.; Wild, C.P. Reducing Social Inequalities in Cancer: Evidence and Priorities for Research; IARC scientific publications, no. 168; International Agency for Research on Cancer: Lyon, France, 2019; pp. 223–226.
- Goss, P.E.; Lee, B.L.; Badovinac-Crnjevic, T.; Strasser-Weippl, K.; Chavarri-Guerra, Y.; Louis, J.S.; Villarreal-Garza, C.; Unger-Saldaña, K.; Ferreyra, M.; Debiasi, M.; et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013, 14, 391–436. [Google Scholar] [CrossRef]
- Amin, M.B.; Greene, F.L.; Edge, S.B.; Compton, C.C.; Gershenwald, J.E.; Brookland, R.K.; Meyer, L.; Gress, D.M.; Byrd, D.R.; Winchester, D.P. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 2017, 67, 93–99. [Google Scholar] [CrossRef] [PubMed]
- Bouvard, V.; Nethan, S.T.; Singh, D.; Warnakulasuriya, S.; Mehrotra, R.; Chaturvedi, A.K.; Chen, T.H.H.; Ayo-Yusuf, O.A.; Gupta, P.C.; Kerr, A.R.; et al. IARC Perspective on Oral Cancer Prevention. N. Engl. J. Med. 2022, 387, 1999–2005. [Google Scholar] [CrossRef] [PubMed]
- Shah, J.P.; Gil, Z. Current concepts in management of oral cancer-surgery. Oral Oncol. 2009, 45, 394–401. [Google Scholar] [CrossRef] [PubMed]
- González-Ruiz, I.; Ramos-García, P.; Ruiz-Ávila, I.; González-Moles, M. Early Diagnosis of Oral Cancer: A Complex Polyhedral Problem with a Difficult Solution. Cancers 2023, 15, 3270. [Google Scholar] [CrossRef]
- Peacock, Z.S.; Pogrel, M.A.; Schmidt, B.L. Exploring the reasons for delay in treatment of oral cancer. J. Am. Dent. Assoc. 2008, 139, 1346–1352. [Google Scholar] [CrossRef]
- Carter, L.M.; Ogden, G.R. Oral cancer awareness of general medical and general dental practitioners. Br. Dent. J. 2007, 203, E10. [Google Scholar] [CrossRef]
- León, X.; Pujals, G.; Bulboa, C.; García, J.; López, M.; Quer, M. Head and neck squamous cell carcinoma in cigar smokers. Distinctive epidemiological and prognostic characteristics. Acta Otorrinolaringol. Esp. 2021, 72, 222–229. [Google Scholar] [CrossRef]
- Auguste, A.; Deloumeaux, J.; Joachim, C.; Gaete, S.; Michineau, L.; Herrmann-Storck, C.; Duflo, S.; Luce, D. Joint effect of tobacco, alcohol, and oral HPV infection on head and neck cancer risk in the French West Indies. Cancer Med. 2020, 9, 6854–6863. [Google Scholar] [CrossRef]
- Yosefof, E.; Hilly, O.; Stern, S.; Bachar, G.; Shpitzer, T.; Mizrachi, A. Squamous cell carcinoma of the oral tongue: Distinct epidemiological profile disease. Head Neck 2020, 42, 2316–2320. [Google Scholar] [CrossRef]
- Abu-Ghanem, S.; Yehuda, M.; Carmel, N.N.; Leshno, M.; Abergel, A.; Gutfeld, O.; Fliss, D.M. Elective Neck Dissection vs Observation in Early-Stage Squamous Cell Carcinoma of the Oral Tongue with No Clinically Apparent Lymph Node Metastasis in the Neck: A Systematic Review and Meta-analysis. JAMA Otolaryngol. Head Neck Surg. 2016, 142, 857–865. [Google Scholar] [CrossRef]
- Mukdad, L.; Heineman, T.E.; Alonso, J.; Badran, K.W.; Kuan, E.C.; St. John, M.A. Oral tongue squamous cell carcinoma survival as stratified by age and sex: A surveillance, epidemiology, and end results analysis. Laryngoscope 2019, 129, 2076–2081. [Google Scholar] [CrossRef] [PubMed]
- Perea, L.M.E.; Antunes, J.L.F.; Peres, M.A. Oral and oropharyngeal cancer mortality in Brazil, 1983–2017: Age-period-cohort analysis. Oral Dis. 2022, 28, 97–107. [Google Scholar] [CrossRef] [PubMed]
- Rusthoven, K.; Ballonoff, A.; Raben, D.; Chen, C. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 2008, 112, 345–351. [Google Scholar] [CrossRef] [PubMed]
- Bagan, J.; Sarrion, G.; Jimenez, Y. Oral cancer: Clinical features. Oral Oncol. 2010, 46, 414–417. [Google Scholar] [CrossRef] [PubMed]
- Scully, C.; Bagan, J. Oral squamous cell carcinoma overview. Oral Oncol. 2009, 45, 301–308. [Google Scholar] [CrossRef]
- Haya-Fernández, M.; Bagán, J.; Murillo-Cortés, J.; Poveda-Roda, R.; Calabuig, C. The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma. Oral Dis. 2004, 10, 346–348. [Google Scholar] [CrossRef]
- Zhang, Y.; Lin, C.; Wang, X.; Ji, T. Calcitonin gene-related peptide: A promising bridge between cancer development and cancer-associated pain in oral squamous cell carcinoma. Oncol. Lett. 2020, 20, 253. [Google Scholar] [CrossRef]
- Goussault, H.; Gendarme, S.; Assié, J.B.; Bylicki, O.; Chouaïd, C. Factors associated with early lung cancer mortality: A systematic review. Expert Rev. Anticancer. Ther. 2021, 21, 1125–1133. [Google Scholar] [CrossRef]
- Zhou, K.; Shi, H.; Chen, R.; Cochuyt, J.J.; Hodge, D.O.; Manochakian, R.; Zhao, Y.; Ailawadhi, S.; Lou, Y. Association of Race, Socioeconomic Factors, and Treatment Characteristics with Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer. JAMA Netw. Open 2021, 4, e2032276. [Google Scholar] [CrossRef]
- Korst, M.R.; Patel, A.M.; Garcia, D.J.; Patel, A.R.; Choudhry, H.S.; Santitoro, J.G.; Yeung, V.; Kra, J.A. Disparities in lung cancer short- and long-term outcomes after surgery: Analysis from the national cancer database. Cancer Treat. Res. Commun. 2023, 37, 100777. [Google Scholar] [CrossRef]
- Neroda, P.; Hsieh, M.-C.; Wu, X.-C.; Cartmell, K.B.; Mayo, R.; Wu, J.; Hicks, C.; Zhang, L. Racial Disparity and Social Determinants in Receiving Timely Surgery Among Stage I-IIIA Non-small Cell Lung Cancer Patients in a U.S. Southern State. Front. Public Health 2021, 9, 662876. [Google Scholar] [CrossRef] [PubMed]
- Jiang, L.; Zhang, A.; Wang, M.; Yang, L.; Ma, L. Perceived social support and distress in carers of people with lung cancer: The serial mediation of resilience and positive aspects of caregiving. Eur. J. Oncol. Nurs. 2022, 56, 102084. [Google Scholar] [CrossRef] [PubMed]
- Litzelman, K.; Reblin, M.; McDowell, H.E.; DuBenske, L.L. Trajectories of social resource use among informal lung cancer caregivers. Cancer 2020, 126, 425–431. [Google Scholar] [CrossRef] [PubMed]
Characteristic | N | % | 95% Confidence Interval | p-Value | |
---|---|---|---|---|---|
Sex | Female | 108 | 46.4 | 39.8–52.9 | 0.26 |
Male | 125 | 53.6 | 47.0–60.2 | ||
Residential | Urban | 149 | 63.9 | 57.3–70.3 | <0.001 |
Rural | 84 | 36.1 | 29.7–42.7 | ||
Education Level | Primary | 119 | 51.1 | 44.6–57.6 | <0.001 |
Secondary | 40 | 17.2 | 12.4–22.9 | ||
Technical/Higher | 5 | 2.1 | 0.7–4.5 | ||
None | 17 | 7.3 | 4.4–11.2 | ||
Not reported | 52 | 22.3 | 17.4–27.9 | ||
Marital status | Married | 111 | 47.6 | 41.1–54.3 | 0.47 |
Single | 122 | 52.4 | 45.7–58.9 | ||
Employment | Formal | 6 | 2.6 | 0.9–5.5 | |
Informal | 111 | 47.6 | 41.1–54.3 | ||
Unemployed | 116 | 49.8 | 43.2–56.4 | <0.001 | |
Health system affiliation | Contributory | 50 | 21.5 | 16.4–27.3 | |
Subsidized | 130 | 55.8 | 49.2–62.3 | <0.001 | |
None | 53 | 22.7 | 17.5–28.7 | ||
Socioeconomic level | Low | 169 | 72.5 | 66.8–77.8 | <0.001 |
Medium | 64 | 27.5 | 22.2–33.2 | ||
High | 0 | 0 | 0 |
Characteristic | N | % | 95% Confidence Interval | p-Value | |
---|---|---|---|---|---|
Smoking | Smoker | 194 | 83.3 | 77.8–87.8 | <0.001 |
Non-smoker | 39 | 16.7 | 12.2–22.2 | ||
Alcohol consumption | Yes | 129 | 55 | 48.3–61.5 | 0.10 |
No | 104 | 45 | 38.5–51.7 | ||
Anatomic location of the lesion | Tongue | 72 | 30.9 | 25.0–37.3 | 0.10 |
Palate | 39 | 16.7 | 12.2–22.2 | ||
Mouth floor | 42 | 18.0 | 13.3–23.6 | ||
Maxillary and mandibular bone | 33 | 14.2 | 10.0–19.3 | ||
Alveolar ridge and retromolar trigone | 28 | 12.0 | 8.1–16.9 | ||
Lip and cheek | 19 | 8.2 | 5.0–12.4 | ||
Family history of cancer | Yes | 17 | 7.3 | 4.3–11.4 | |
No | 216 | 92.7 | 88.5–95.7 | <0.001 | |
Stage of the disease | Early | 37 | 15.9 | 11.4–21.2 | |
Advanced | 196 | 84.1 | 78.8–88.6 | <0.001 | |
Treatment | Surgery | 46 | 19.7 | 14.8–25.4 | 0.47 |
Radiation therapy and chemotherapy (palliative treatment) | 54 | 23.2 | 18.0–29.1 | ||
Surgery, radiation therapy and chemotherapy | 92 | 39.5 | 33.2–46.1 | ||
Clinical pain remission | 41 | 17.6 | 13.0–23.1 | ||
Retreatment | Yes | 29 | 12.4 | 8.5–17.4 | |
No | 204 | 87.6 | 82.6–91.5 | <0.001 | |
Recurrence | Yes | 22 | 9.4 | 6.0–14.0 | |
No | 211 | 90.6 | 86.0–94.0 | <0.001 |
Variable | Advanced Stage | Early Stage | % Advanced Stage | p-Value | RR * | 95% Confidence Interval | |
---|---|---|---|---|---|---|---|
Sex | Male | 114 | 11 | 91.2 | 0.001 | 1.2 | 1.1–1.4 |
Female | 82 | 26 | 75.9 | 1 | |||
Residential | Rural | 73 | 10 | 88.0 | 0.226 | 1.1 | 1.0–1.2 |
Urban | 122 | 27 | 81.9 | 1 | |||
Education Level | Primary | 114 | 22 | 83.9 | 0.555 | 1.1 | 0.9–1.2 |
Secondary | 36 | 9 | 80.0 | 1 | |||
Marital status | Single | 103 | 19 | 84.4 | 0.9 | 1.0 | 0.9–1.1 |
Married | 93 | 18 | 83.8 | 1 | |||
Employment | Unemployed | 95 | 21 | 81.9 | 1.000 | 1.0 | 0.7–1.4 |
Informal | 96 | 15 | 86.5 | 1.000 | 1.0 | 0.7–1.5 | |
Formal | 5 | 1 | 83.3 | 1 | |||
Health system affiliation | None | 45 | 8 | 84.9 | 0.02 | 1.2 | 1.0–1.4 |
Subsidized | 114 | 16 | 87.7 | 0.02 | 1.2 | 1.0–1.4 | |
Contributory | 37 | 13 | 74.0 | 1 | |||
Socioeconomic level | Low | 142 | 25 | 85.0 | 0.5 | 1.1 | 0.9–1.2 |
Medium | 52 | 12 | 81.2 | 1 |
Clinical Variable | Advanced Stage | Early Stage | % Advanced Stage | p-Value | RR * | 95% Confidence Interval | |
---|---|---|---|---|---|---|---|
Smoking | Smoker | 167 | 27 | 86.1 | 0.068 | 1.1 | 0.9–1.4 |
Non-Smoker | 29 | 10 | 74.3 | 1 | |||
Alcohol consumption | Yes | 111 | 16 | 87.4 | 0.117 | 1.1 | 1.0–1.2 |
No | 83 | 21 | 80.0 | 1 | |||
Anatomic location of the lesion | Tongue | 55 | 17 | 76.3 | 0.04 | 0.9 | 0.7–1.0 |
Palate | 33 | 6 | 84.6 | 0.563 | 0.9 | 0.8–1.1 | |
Mouth floor | 37 | 5 | 88.1 | 1.000 | 1.0 | 0.9–1.1 | |
Maxillary/other sites | 71 | 9 | 88.8 | 1 | |||
Family history of cancer | Yes | 16 | 1 | 94.1 | 0.487 | 1.1 | 0.1–1.3 |
No | 180 | 36 | 83.3 | 1 | |||
Treatment | Clinical pain remission | 40 | 1 | 97.5 | 0.0001 | 1.5 | 1.2–1.8 |
Surgery, radiation therapy and chemotherapy | 126 | 20 | 86.3 | 0.001 | 1.3 | 1.1–1.6 | |
Surgery | 30 | 16 | 62.5 | 1 | |||
Retreatment | Yes | 26 | 3 | 89.6 | 0.587 | 1.1 | 0.9–1.2 |
No | 170 | 34 | 83.3 | 1 | |||
Recurrence | Yes | 21 | 1 | 95.4 | 0.216 | 1.2 | 1.0–1.3 |
No | 175 | 36 | 82.9 | 1 |
Variable | Beta | Total Error | Wald | Degrees of Freedom | p-Value | Exponential B | 95% Confidence Interval |
---|---|---|---|---|---|---|---|
Sex | 1.131 | 0.407 | 7.730 | 1 | 0.005 | 3.099 | 1.396–6.879 |
Surgery | 11.845 | 2 | 0.003 | ||||
Treatment combination | 1.106 | 0.414 | 7.147 | 1 | 0.008 | 3.022 | 1.343–6.798 |
Clinical pain remission | 2.969 | 1.073 | 7.657 | 1 | 0.006 | 19.5 | 2.378–159.561 |
Contributory | 4.577 | 2 | 0.101 | ||||
None | 0.918 | 0.544 | 4.590 | 1 | 0.002 | 2.749 | 1.173–6.406 |
Subsidized | 0.956 | 0.453 | 4.453 | 1 | 0.035 | 2.602 | 1.070–6.326 |
Constant | −0.379 | 0.465 | 0.663 | 1 | 0.415 | 0.685 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Díaz-Laclaustra, A.I.; Álvarez-Martínez, E.; Ardila, C.M. Influence of Health System Affiliation and Pain Manifestation on Advanced Oral Cavity Squamous Cell Carcinoma Risk: A Retrospective Cohort Study in a Latin American Population. Dent. J. 2024, 12, 383. https://doi.org/10.3390/dj12120383
Díaz-Laclaustra AI, Álvarez-Martínez E, Ardila CM. Influence of Health System Affiliation and Pain Manifestation on Advanced Oral Cavity Squamous Cell Carcinoma Risk: A Retrospective Cohort Study in a Latin American Population. Dentistry Journal. 2024; 12(12):383. https://doi.org/10.3390/dj12120383
Chicago/Turabian StyleDíaz-Laclaustra, Alejandro I., Efraín Álvarez-Martínez, and Carlos M. Ardila. 2024. "Influence of Health System Affiliation and Pain Manifestation on Advanced Oral Cavity Squamous Cell Carcinoma Risk: A Retrospective Cohort Study in a Latin American Population" Dentistry Journal 12, no. 12: 383. https://doi.org/10.3390/dj12120383
APA StyleDíaz-Laclaustra, A. I., Álvarez-Martínez, E., & Ardila, C. M. (2024). Influence of Health System Affiliation and Pain Manifestation on Advanced Oral Cavity Squamous Cell Carcinoma Risk: A Retrospective Cohort Study in a Latin American Population. Dentistry Journal, 12(12), 383. https://doi.org/10.3390/dj12120383